ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

{"_buckets": {"deposit": "890f20c8-71ba-4913-80bc-0578428bffca"}, "_deposit": {"id": "12019", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "12019"}, "status": "published"}, "_oai": {"id": "oai:niigata-u.repo.nii.ac.jp:00012019", "sets": ["456", "1012"]}, "item_7_alternative_title_1": {"attribute_name": "その他のタイトル", "attribute_value_mlt": [{"subitem_alternative_title": "Multimodality Therapy for Lung Cancer"}]}, "item_7_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2006-08", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "8", "bibliographicPageEnd": "429", "bibliographicPageStart": "425", "bibliographicVolumeNumber": "120", "bibliographic_titles": [{"bibliographic_title": "新潟医学会雑誌"}, {"bibliographic_title": "新潟医学会雑誌", "bibliographic_titleLang": "en"}]}]}, "item_7_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Lung cancer is the leading cause of cancer mortality in the world. In Japan, lung cancer was responsible for 41634 of men and 15086 of women death in 2003, accounting for 18.3% of all cancer death each year and approximately 100,000 death will occur in 2010. Despite chemotherapy with new agents have been shown to improve the survival and quality of life in patients with lung cancer, curable patient is still rare. Molecular target therapy, cellular therapy could be powerful arms to overcome this stagnant situation. Moreover, combination of these treatment modalities, i.e., multimodality therapy should improve the prognosis of patients with lung cancer.", "subitem_description_type": "Abstract"}]}, "item_7_full_name_3": {"attribute_name": "著者別名", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "80959", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Yoshizawa, Hiroshisa"}]}]}, "item_7_publisher_7": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "新潟医学会"}]}, "item_7_rights_15": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "本文データは学協会の許諾に基づきCiNiiから複製したものである"}]}, "item_7_select_19": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_7_source_id_11": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00182415", "subitem_source_identifier_type": "NCID"}]}, "item_7_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00290440", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "吉澤, 弘久"}], "nameIdentifiers": [{"nameIdentifier": "80958", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2019-08-07"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "110006483470.pdf", "filesize": [{"value": "590.7 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 590700.0, "url": {"label": "110006483470.pdf", "url": "https://niigata-u.repo.nii.ac.jp/record/12019/files/110006483470.pdf"}, "version_id": "486067f2-898c-4120-b528-60ba9c9c6b4b"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "lung cancer", "subitem_subject_scheme": "Other"}, {"subitem_subject": "chemotherapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "molecular target", "subitem_subject_scheme": "Other"}, {"subitem_subject": "cellular therapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "multimodality therapy", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "肺癌に対する集学的治療", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "肺癌に対する集学的治療"}, {"subitem_title": "肺癌に対する集学的治療", "subitem_title_language": "en"}]}, "item_type_id": "7", "owner": "1", "path": ["456", "1012"], "permalink_uri": "http://hdl.handle.net/10191/19862", "pubdate": {"attribute_name": "公開日", "attribute_value": "2012-10-17"}, "publish_date": "2012-10-17", "publish_status": "0", "recid": "12019", "relation": {}, "relation_version_is_last": true, "title": ["肺癌に対する集学的治療"], "weko_shared_id": null}
  1. 0 資料タイプ別
  2. 03 紀要論文
  1. 250 大学院医歯学総合研究科(医)
  2. 20 紀要
  3. 02 新潟医学会雑誌
  4. 第120巻第8号

肺癌に対する集学的治療

http://hdl.handle.net/10191/19862
http://hdl.handle.net/10191/19862
adb1efaf-c322-4687-9c67-b6661deff4e7
名前 / ファイル ライセンス アクション
110006483470.pdf 110006483470.pdf (590.7 kB)
Item type 紀要論文 / Departmental Bulletin Paper(1)
公開日 2012-10-17
タイトル
タイトル 肺癌に対する集学的治療
タイトル
言語 en
タイトル 肺癌に対する集学的治療
言語
言語 jpn
キーワード
主題Scheme Other
主題 lung cancer
キーワード
主題Scheme Other
主題 chemotherapy
キーワード
主題Scheme Other
主題 molecular target
キーワード
主題Scheme Other
主題 cellular therapy
キーワード
主題Scheme Other
主題 multimodality therapy
資源タイプ
資源 http://purl.org/coar/resource_type/c_6501
タイプ departmental bulletin paper
その他のタイトル
その他のタイトル Multimodality Therapy for Lung Cancer
著者 吉澤, 弘久

× 吉澤, 弘久

WEKO 80958

吉澤, 弘久

Search repository
著者別名
識別子 80959
識別子Scheme WEKO
姓名 Yoshizawa, Hiroshisa
抄録
内容記述タイプ Abstract
内容記述 Lung cancer is the leading cause of cancer mortality in the world. In Japan, lung cancer was responsible for 41634 of men and 15086 of women death in 2003, accounting for 18.3% of all cancer death each year and approximately 100,000 death will occur in 2010. Despite chemotherapy with new agents have been shown to improve the survival and quality of life in patients with lung cancer, curable patient is still rare. Molecular target therapy, cellular therapy could be powerful arms to overcome this stagnant situation. Moreover, combination of these treatment modalities, i.e., multimodality therapy should improve the prognosis of patients with lung cancer.
書誌情報 新潟医学会雑誌
en : 新潟医学会雑誌

巻 120, 号 8, p. 425-429, 発行日 2006-08
出版者
出版者 新潟医学会
ISSN
収録物識別子タイプ ISSN
収録物識別子 00290440
書誌レコードID
収録物識別子タイプ NCID
収録物識別子 AN00182415
権利
権利情報 本文データは学協会の許諾に基づきCiNiiから複製したものである
著者版フラグ
値 publisher
戻る
0
views
See details
Views

Versions

Ver.1 2021-03-01 17:20:00.878722
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3